戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 entation in gestational weeks (GWs) -4 to 8 (periconceptional), 9 to 12, and -4 to 12, and supplement
2                                              Periconceptional administration of folic acid can reduce
3  the association between maternal reports of periconceptional alcohol consumption and clefting.
4 d with that of 9 infants born to women whose periconceptional alcohol intake averaged > or = 30mL abs
5  This study examined the effects of maternal periconceptional alcohol intake on polyunsaturated fatty
6                                              Periconceptional alcohol use was associated with a 30% i
7 ry inflammatory potential and quality during periconceptional and antenatal periods on birth outcomes
8  but evidence is limited on whether maternal periconceptional and early pregnancy adherence is associ
9 ssion to 2%, 5%, and 16% in preconceptional, periconceptional, and T1 periods, respectively (P = .034
10 spontaneous or induced abortions) by type of periconceptional antiretroviral exposure.
11 trol study, we investigated whether parental periconceptional cigarette smoking was associated with a
12                 Dietary patterns with a high periconceptional density of fruits and vegetables appear
13 nvestigated the associations between women's periconceptional diet and gestational diabetes risk.
14                                              Periconceptional diet may persistently influence DNA met
15  of further investigation into the effect of periconceptional diet on OFC occurrence.
16                                              Periconceptional diet was recalled at recruitment, using
17                                        Usual periconceptional dietary intake was assessed at 6-13 wk
18    The authors investigated whether maternal periconceptional dietary intakes of choline and its meta
19 icaid data that were associated with HIV and periconceptional dolutegravir exposure.
20 es in risk ratios of NTD between groups with periconceptional dolutegravir or non-dolutegravir antire
21 ian adults and show, in rural Gambians, that periconceptional environment affects offspring VTRNA2-1
22 ss diverse human ethnic groups, sensitive to periconceptional environment, and associated with genes
23 enriched for loci previously associated with periconceptional environment, parent-of-origin-specific
24 thylation is reported to be sensitive to the periconceptional environment.
25 each pregnancy, we determined HIV status and periconceptional exposure to dolutegravir or other antir
26 rential DNA methylation in whole blood after periconceptional exposure to famine during the Dutch Hun
27                         To determine whether periconceptional exposure to folic acid antagonists (FAA
28 nvestigated the association between maternal periconceptional exposure to nitrate from drinking water
29 associations between neural tube defects and periconceptional exposure to NSDs containing a secondary
30                                              Periconceptional exposure to Ramadan was associated with
31                                              Periconceptional exposure to second-line noninsulin ADMs
32                                              Periconceptional exposure was defined as 1 or more presc
33 interval (<6, 6-11, 12-17, and 18-23 mo) and periconceptional FA intake [no FA supplement use and die
34  Mean IQs were higher in children exposed to periconceptional folate (108, 95% CI 106-111) than they
35 aluated variable DNA methylation response to periconceptional folate by ALL case status through an in
36 tudy (CCLS) from 1995-2008 was compared with periconceptional folate from total, food, and supplement
37                           Mechanisms whereby periconceptional folate influences normal development an
38    We identified modest associations between periconceptional folate intake and DNA methylation diffe
39 rnal hazardous and noxious substances (HNS), periconceptional folate intake and paternal smoking.
40            We evaluated the relation between periconceptional folate intake by source and DNA methyla
41 ) were associated with food and supplemental periconceptional folate intake in all subjects (n = 394)
42                                              Periconceptional folate intake is associated with the es
43                                              Periconceptional folate is essential for proper neurodev
44 ide future analyses of the causal effects of periconceptional folate levels on candidate pathways.
45  and education appear uniquely responsive to periconceptional folate supplementation.
46                  The positive association of periconceptional folate with IQ is consistent with other
47 ised dose, gestational birth age, and use of periconceptional folate.
48                                              Periconceptional folic acid (FA) supplementation is reco
49                                              Periconceptional folic acid may reduce ASD risk in those
50 ore substantial evidence about the effect of periconceptional folic acid on the occurrence of congeni
51                 In the 1990s, the utility of periconceptional folic acid supplementation and folic ac
52                                              Periconceptional folic acid supplementation and food for
53 ndings do not support an association between periconceptional folic acid supplementation and increase
54                                              Periconceptional folic acid supplementation is a primary
55                                              Periconceptional folic acid supplementation reduces the
56                                              Periconceptional folic acid supplementation reduces the
57                                              Periconceptional folic acid supplementation was not asso
58 lts are adjusted for region, interview year, periconceptional folic acid supplementation, maternal ag
59 a bifida cases can be prevented by maternal, periconceptional folic acid supplementation.
60 e of preterm birth was 13.2% in women with a periconceptional HbA1c level below 6.5% (adjusted risk r
61 isk for preterm birth was strongly linked to periconceptional HbA1c levels.
62 NA methylation at human CoRSIVs is labile to periconceptional influences such as nutrition.
63                                              Periconceptional intake of 400 microg of folic acid dail
64                                              Periconceptional intake of folic acid prevents some neur
65                                  Usual daily periconceptional intake of total fruits and total vegeta
66                                  Usual daily periconceptional intake of total fruits and total vegeta
67 interaction between infant RFC1 genotype and periconceptional intake of vitamins on the risk of conot
68 uality evidence of the effect of prenatal or periconceptional iodine supplementation on growth and co
69 ic health nurse (aOR, 0.2; 95% CI, 0.1-0.8), periconceptional maternal alcohol use (aOR, 6.2; 95% CI,
70          We assessed the association between periconceptional maternal diet and OFC in the United Sta
71 ortality; they can largely be prevented with periconceptional maternal intake of folic acid.
72                          The hypothesis that periconceptional maternal micronutrient supplementation
73 al, and it provides suggestive evidence that periconceptional maternal nutrition alters offspring met
74 fspring PAX8 methylation was associated with periconceptional maternal nutrition, and methylation var
75                                              Periconceptional maternal use of cocaine (odds ratio (OR
76 iscuss the role of the maternal decidua, the periconceptional maternal-embryonic interface, the dialo
77 lind randomized-controlled trial of pre- and periconceptional micronutrient supplementation (includin
78             A randomized controlled trial of periconceptional micronutrient supplementation in The Ga
79                       Significant effects of periconceptional micronutrient supplementation were also
80 lacental vascular function was modifiable by periconceptional micronutrient supplementation.
81                We tested the hypothesis that periconceptional multiple-micronutrient supplementation
82                Information is summarized for periconceptional multivitamin or folic acid intake, whic
83                      The association between periconceptional multivitamin use and PTBs varied accord
84 ective was to determine the relation between periconceptional multivitamin use and the risk of small-
85                  The timing and frequency of periconceptional multivitamin use may be related to the
86  to assess the independent effect of regular periconceptional multivitamin use on the risk of preecla
87       We related the timing and frequency of periconceptional multivitamin use to SGA births and PTBs
88                                              Periconceptional multivitamin use was associated with a
89                                      Regular periconceptional multivitamin use was associated with a
90 ment gestational age, and household density, periconceptional multivitamin use was associated with a
91                 Early studies suggested that periconceptional multivitamin use was associated with an
92                                      Regular periconceptional multivitamin use was associated with re
93                                              Periconceptional multivitamin use, defined as reported r
94 psia (2.3%), and 18,551 women (65%) reported periconceptional multivitamin use.
95  major cardiac defects could be prevented by periconceptional multivitamin use.
96 lded inconsistent results for the effects of periconceptional multivitamins containing folic acid and
97                                The intake of periconceptional multivitamins may decrease the risk of
98                                              Periconceptional NSAIDs reported through the sixth week
99 cted from 1998 to 2012, we compared maternal periconceptional NSD use between 334 neural tube defect
100 atively small, these pilot data suggest that periconceptional nutrition in humans is an important det
101  profiles are associated with their mother's periconceptional nutritional status.
102 ntified as changes observed after randomized periconceptional nutritional supplementation in a Gambia
103           Gender-specific changes related to periconceptional nutritional supplementation were identi
104  studied the largest US cohort of women with periconceptional or early-pregnancy dolutegravir exposur
105    We investigated whether higher intakes of periconceptional or midpregnancy folate, as recommended,
106       The asthma medications used during the periconceptional period (1 month prepregnancy through th
107 terval (CI): 1.00, 3.67), smoking during the periconceptional period (aOR = 2.09, 95% CI: 1.08, 4.03)
108 lements and dietary intakes during a 6-month periconceptional period (from 3 months before conception
109  folate-only supplement use during a 12-week periconceptional period (from 4 weeks prior to 8 weeks a
110 s and 3 sources of social support during the periconceptional period among mothers of 593 gastroschis
111 urse visits, maternal alcohol use during the periconceptional period and first trimester, and layers
112 e can be altered by maternal diet during the periconceptional period and that these programming event
113 en maternal asthma medication use during the periconceptional period and the risk of gastroschisis.
114          Pregnancy is established during the periconceptional period as a continuum beginning with bl
115    Maternal nutrition exclusively during the periconceptional period can induce remarkable effects on
116      Daily folic acid supplementation in the periconceptional period can prevent neural tube defects.
117 dine supplementation during pregnancy or the periconceptional period in regions of severe iodine defi
118 perimental animals, maternal diet during the periconceptional period influences the establishment of
119 ular use of a multivitamin supplement in the periconceptional period may help to prevent preeclampsia
120 dine supplementation during pregnancy or the periconceptional period on the development and growth of
121 eroconversions, 29% (33/115) occurred in the periconceptional period or in the first trimester.
122  (33/115) of seroconversions occurred in the periconceptional period or in the first trimester.
123   Although adequate folate intake during the periconceptional period prevents neural tube defects, an
124        Folic acid supplementation during the periconceptional period reduces the risk of neural tube
125 s that folic acid supplementation during the periconceptional period reduces the risk of oral clefts.
126 hypotheses that maternal exposure during the periconceptional period to multivitamins or liver consum
127        Exposure to G/R infections during the periconceptional period was associated with a significan
128                  Maternal smoking during the periconceptional period was not associated with risk of
129 rs of multiple asthma medications during the periconceptional period were also examined.
130 significant ORs for use that began after the periconceptional period were observed for cleft palate o
131  daily folic acid supplementation during the periconceptional period were: oral clefts, 1.1 (95% conf
132  the first trimester (or first trimester and periconceptional period), with no reports of birth defec
133 is that maternal micronutrient status in the periconceptional period, and throughout pregnancy and la
134 supplements containing folic acid during the periconceptional period, the number of children born wit
135  clomiphene (without ART) and ART during the periconceptional period.
136 water at home, and dietary intake during the periconceptional period.
137 idence for higher risk of CL/P with maternal periconceptional smoking in infants with an NOS3 -922G a
138    Finally, we discuss the myometrium in the periconceptional space and review its role in determinin
139 s review, we discuss current advances in the periconceptional space, including the preimplantation hu
140                                              Periconceptional supplement use did not reduce the risk
141 e, and public health guidelines recommending periconceptional supplementation have increased folic ac
142 n the absence of clinical folate deficiency, periconceptional supplementation with folic acid reduces
143                      Animal models show that periconceptional supplementation with folic acid, vitami
144  risk of neural tube defects is decreased by periconceptional supplementation with folic acid.
145 of CP, while no association was observed for periconceptional supplementation.
146                  In conclusion, twinning and periconceptional undernutrition are associated with epig
147  to gestational timing categories, including periconceptional use (28 days before through 28 days aft
148 etween cases and controls assessing maternal periconceptional use of folic acid and intake of dietary
149                                              Periconceptional use of folic acid containing supplement
150 support a protective association between the periconceptional use of folic acid supplements and the r
151 1%, 25.2%, and 26.1%, respectively, reported periconceptional use of folic acid supplements.
152 k among the fetuses or infants of women with periconceptional use of folic acid was also significant
153 ong the fetuses or infants of the women with periconceptional use of folic acid, the rates were 1.0 p
154                                          The periconceptional use of folic acid-containing supplement
155  other birth defects may be prevented by the periconceptional use of folic acid.
156 rs investigated whether maternal or paternal periconceptional use of recreational drugs increased the
157 ube defect risk was associated with maternal periconceptional use of secondary (adjusted odds ratio (
158 known for the past two decades that maternal periconceptional use of the B vitamin folic acid can pre
159                                     Maternal periconceptional use of vitamin supplements containing f
160 teraction between the RFC1 gene and maternal periconceptional use of vitamins containing folic acid.
161 ubgroup of women in the northern region with periconceptional use who took folic acid pills more than
162                    In contrast, prenatal and periconceptional use, compared with nonuse, were not rel
163                                          For periconceptional use, ORs with 95% confidence intervals
164       These data support the hypothesis that periconceptional vitamin supplementation may extend bene
165 rol infants for whom information on maternal periconceptional vitamin use was available.
166 m births and extreme SGA in women who report periconceptional vitamin use, although these should be c
167  After adjustment for race, body mass index, periconceptional vitamin use, and gestational age at sam

 
Page Top